Mitochondrial Iron Metabolism and Sideroblastic Anemia

Sideroblastic anemias are a heterogeneous group of disorders, characterized by mitochondrial iron overload in developing red blood cells. The unifying characteristic of all sideroblastic anemias is the ring sideroblast, which is a pathological erythroid precursor containing excessive deposits of non-heme iron in mitochondria with perinuclear distribution creating a ring appearance. Sideroblastic anemias may be hereditary or acquired. Hereditary sideroblastic anemias are caused by defects in genes present on the X chromosome (mutations in the ALAS2, ABCB7, or GRLX5 gene), genes on autosomal chromosomes, or mitochondrial genes. Acquired sideroblastic anemias are either primary (refractory anemia with ring sideroblasts, RARS, representing one subtype of the myelodysplastic syndrome) or secondary due to some drugs, toxins, copper deficiency, or chronic neoplastic disease. The pathogenesis of mitochondrial iron loading in developing erythroblasts is diverse. Ring sideroblasts can develop as a result of a heme synthesis defect in erythroblasts (ALAS2 mutations), a defect in iron-sulfur cluster assembly, iron-sulfur protein precursor release from mitochondria (ABCB7 mutations), or by a defect in intracellular iron metabolism in erythroid cells (e.g. RARS).

[1]  D. Richardson,et al.  Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant , 2009, Proceedings of the National Academy of Sciences.

[2]  D. Richardson,et al.  Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors. , 2009, Journal of medicinal chemistry.

[3]  M. Fleming,et al.  Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia , 2009, Nature Genetics.

[4]  Robert L. Jones,et al.  Trends in Blood Lead Levels and Blood Lead Testing Among US Children Aged 1 to 5 Years, 1988–2004 , 2009, Pediatrics.

[5]  R. Lill,et al.  The power plant of the cell is also a smithy: The emerging role of mitochondria in cellular iron homeostasis , 2009, Annals of medicine.

[6]  B. Bain,et al.  Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts , 2008, Haematologica.

[7]  C. Camaschella Recent advances in the understanding of inherited sideroblastic anaemia , 2008, British journal of haematology.

[8]  Joanne,et al.  C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. , 2008, American journal of human genetics.

[9]  M. Hentze,et al.  Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. , 2008, Annual review of nutrition.

[10]  D. Richardson,et al.  The MCK mouse heart model of Friedreich's ataxia: Alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation , 2008, Proceedings of the National Academy of Sciences.

[11]  R. Lill,et al.  Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. , 2008, Annual review of biochemistry.

[12]  Luca Malcovati,et al.  The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts , 2008, PloS one.

[13]  A. Iolascon,et al.  The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. , 2007, Blood.

[14]  M. Fleming,et al.  Abcb7, the gene responsible for X-linked sideroblastic anemia with ataxia, is essential for hematopoiesis. , 2007, Blood.

[15]  Claire M. Brown,et al.  Direct interorganellar transfer of iron from endosome to mitochondrion. , 2006, Blood.

[16]  B. Paw,et al.  Abnormal Expression of Human Mitoferrin (SLC25A37) Is Associated with a Variant of Erythropoietic Protoporphyria. , 2006 .

[17]  Daxi Sun,et al.  Identification of a mammalian mitochondrial porphyrin transporter , 2006, Nature.

[18]  H. Elsässer,et al.  Role of Human Mitochondrial Nfs1 in Cytosolic Iron-Sulfur Protein Biogenesis and Iron Regulation , 2006, Molecular and Cellular Biology.

[19]  T. Ganz,et al.  Regulation of iron metabolism by hepcidin. , 2006, Annual review of nutrition.

[20]  M. Shepherd,et al.  A new class of [2Fe-2S]-cluster-containing protoporphyrin (IX) ferrochelatases. , 2006, The Biochemical journal.

[21]  J. Phillips,et al.  Biosynthesis of heme in mammals. , 2006, Biochimica et biophysica acta.

[22]  H. Elsässer,et al.  Mechanisms of iron-sulfur protein maturation in mitochondria, cytosol and nucleus of eukaryotes. , 2006, Biochimica et biophysica acta.

[23]  D. Winge,et al.  The effects of mitochondrial iron homeostasis on cofactor specificity of superoxide dismutase 2 , 2006, The EMBO journal.

[24]  J. Kutok,et al.  The mitochondrial ATP-binding cassette transporter Abcb7 is essential in mice and participates in cytosolic iron-sulfur cluster biogenesis. , 2006, Human molecular genetics.

[25]  A. Brownlie,et al.  Mitoferrin is essential for erythroid iron assimilation , 2006, Nature.

[26]  J. J. Sharp,et al.  Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells , 2005, Nature Genetics.

[27]  D. Jahn,et al.  Crystal structure of 5‐aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans , 2005, The EMBO journal.

[28]  B. Paw,et al.  Deficiency of glutaredoxin 5 reveals Fe–S clusters are required for vertebrate haem synthesis , 2005, Nature.

[29]  J. Prchal,et al.  Divalent metal transporter 1 , 2005, Hematology.

[30]  D. Richardson,et al.  Iron trafficking in the mitochondrion: novel pathways revealed by disease. , 2005, Blood.

[31]  H. Elsässer,et al.  Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. , 2004, Human molecular genetics.

[32]  K. Furuyama,et al.  Role of the heme regulatory motif in the heme-mediated inhibition of mitochondrial import of 5-aminolevulinate synthase. , 2004, Journal of biochemistry.

[33]  Y. Bykhovskaya,et al.  Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). , 2004, American journal of human genetics.

[34]  K. Iwai,et al.  Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis , 2004, The EMBO journal.

[35]  V. Culotta,et al.  Manganese activation of superoxide dismutase 2 in Saccharomyces cerevisiae requires MTM1, a member of the mitochondrial carrier family , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Kajigaya,et al.  Mitochondrial DNA mutations in patients with myelodysplastic syndromes. , 2003, Blood.

[37]  M. Cazzola,et al.  Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. , 2003, Blood.

[38]  M. Knutson,et al.  Iron Metabolism in the Reticuloendothelial System , 2003, Critical reviews in biochemistry and molecular biology.

[39]  H. Dailey,et al.  Characterization of a human and mouse tetrapyrrole-binding protein. , 2002, Archives of biochemistry and biophysics.

[40]  M. Fleming The genetics of inherited sideroblastic anemias. , 2002, Seminars in hematology.

[41]  J. Prchal,et al.  Copper deficiency masquerading as myelodysplastic syndrome. , 2002, Blood.

[42]  K. Furuyama,et al.  Multiple mechanisms for hereditary sideroblastic anemia. , 2002, Cellular and molecular biology.

[43]  L. Goldman,et al.  Iron deficiency associated with higher blood lead in children living in contaminated environments. , 2001, Environmental health perspectives.

[44]  P. Arosio,et al.  A Human Mitochondrial Ferritin Encoded by an Intronless Gene* , 2001, The Journal of Biological Chemistry.

[45]  C. Lok,et al.  Identification of an Erythroid Active Element in the Transferrin Receptor Gene* , 2000, The Journal of Biological Chemistry.

[46]  K. Furuyama,et al.  Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia. , 2000, The Journal of clinical investigation.

[47]  N. Gattermann,et al.  From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes. , 2000, Leukemia research.

[48]  A. Hutchinson,et al.  Mutation of a Putative Mitochondrial Iron Transporter Gene (ABC7) in X-Linked Sideroblastic Anemia and Ataxia (XLSA/A) , 1999, Human molecular genetics.

[49]  D. Richardson,et al.  The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. , 1997, Biochimica et biophysica acta.

[50]  D. Richardson,et al.  Distribution of iron in reticulocytes after inhibition of heme synthesis with succinylacetone: examination of the intermediates involved in iron metabolism. , 1996, Blood.

[51]  H. Faille,et al.  Accumulation of iron in erythroblasts of patients with erythropoietic protoporphyria , 1993, European journal of clinical investigation.

[52]  T. Cox,et al.  Human erythroid 5‐aminolevulinate synthase: promoter analysis and identification of an iron‐responsive element in the mRNA. , 1991, The EMBO journal.

[53]  A. Pagliuca,et al.  Lead poisoning: clinical, biochemical, and haematological aspects of a recent outbreak. , 1990, Journal of clinical pathology.

[54]  S H Snyder,et al.  Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R. Hoffman,et al.  A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. , 1979, The Journal of pediatrics.

[56]  A. Carroll,et al.  A common progenitor for human myeloid and lymphoid cells , 1978, Nature.

[57]  M. Losowsky,et al.  The Distribution of Erythroblast Iron in Sideroblastic Anaemias , 1966, British journal of haematology.

[58]  P. Kuchel,et al.  Hepcidin, the hormone of iron metabolism, is bound specifically to -2-macroglobulin in blood , 2009 .

[59]  P. Arosio,et al.  causes an iron-deficient phenotype with mitochondrial iron overload RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells , 2009 .

[60]  Jerry Kaplan,et al.  Regulation of iron acquisition and storage: consequences for iron-linked disorders , 2008, Nature Reviews Molecular Cell Biology.

[61]  N. Andrews,et al.  Iron homeostasis and erythropoiesis. , 2008, Current topics in developmental biology.

[62]  Maya Shvartsman,et al.  Intracellular labile iron. , 2008, The international journal of biochemistry & cell biology.

[63]  P. Ponka,et al.  Intracellular kinetics of iron in reticulocytes: evidence for endosome involvement in iron targeting to mitochondria. , 2005, Blood.

[64]  J. Tolmie,et al.  Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation. , 2000, Blood.

[65]  P. Ponka Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. , 1997, Blood.

[66]  E. Beutler Hereditary and acquired sideroblastic anemias , 1995 .

[67]  I. Bernát Sándor,et al.  [Sideroblastic anemias]. , 1991, Orvosi hetilap.